Micah Benson
Company: KSQ Therapeutics
Job title: Head of Immunology
Seminars:
TIL therapies: At the cellular level Q&A + Open Counsel 6:05 pm
day: Conference Day
CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTILTM) Therapies for Solid Tumors 5:15 pm
Systematic identification of genes restoring and amplifying T cell function in the tumor microenvironment Divulging updates on KSQ-001 and next generation TIL approaches Lessons learnt from the use of CRISPR/Cas9 for T cell rejuvenation and enhanced stability within the tumor microenvironmentRead more
day: Conference Day